In brief
The Centers for Disease Control and Prevention announced 5,182 confirmed measles cases in the United States for 2026, the highest figure since 1991. Roughly 59 percent of cases involve children and teens, while a recent dispute over death classification in Pennsylvania has highlighted inconsistencies between state and federal reporting. Vaccine coverage for kindergarteners has fallen to 92.4 percent in the 2025‑2026 school year, raising concerns about future outbreaks.
The Centers for Disease Control and Prevention (CDC) announced on March 18, 2026 that 5,182 measles cases have been confirmed in the United States to date this year, a figure that represents the highest annual total recorded by the agency in 35 years. The report notes that nearly 60 percent of the confirmed cases involve children and teenagers, with children under five accounting for 18 percent and those aged five to 19 making up 41 percent of all cases.
More than four‑thousand of the reported infections (4,993) are classified as outbreak‑associated, indicating that the majority of cases are linked to specific clusters rather than isolated sporadic occurrences. The CDC points out that the number of cases is more than double the 2,289 measles infections reported in 2025, pointing to a sharp upswing in the disease’s spread.
At the state level, Pennsylvania has emerged as the hardest hit, with the Department of Health reporting 1,487 cases and six deaths in 2026. This contrasts with the CDC’s national total of four deaths, leading to a public dispute between Pennsylvania Governor Josh Shapiro and U.S. Health Secretary Robert F. Kennedy Jr. Shapiro’s office counts deaths that occur within thirty days of a confirmed measles diagnosis as “measles-associated,” while the CDC has so far excluded such deaths from its national tally after Kennedy questioned the methodology.
The disagreement takes place against the backdrop of a broader debate over how measles deaths are defined and reported. Pennsylvania’s policy is to record every death that coincides with a confirmed measles case within a month unless the death results from an unrelated event, whereas the CDC’s approach has so far been more restrictive. The debate was sparked after Pennsylvania reported that two unvaccinated residents died from measles in August; the CDC initially included those deaths in its national count but subsequently removed them following Kennedy’s inquiry.
One factor highlighted by the CDC as a potential driver of the surge is a decline in vaccination coverage among kindergarteners. Coverage fell from 95.2 percent in the 2019‑2020 school year to 92.4 percent in the 2025‑2026 academic year, according to the agency’s data. This dip falls short of the herd‑immunity threshold for measles, which experts estimate at about 95 percent, raising concerns that lower coverage could enable larger outbreaks.
Public health experts have noted that the current outbreak’s age distribution mirrors that seen in previous measles resurgences, where deficiencies in routine immunization and pockets of vaccine hesitancy create fertile ground for transmission. In 2025, nationwide measles incidence had already risen compared to the early decade of the 2000s, but the jump to more than 5,000 cases this year has intensified calls for a coordinated response from federal and state agencies.
In addition to the disagreement over death figures, questions remain about how the CDC classifies and aggregates outbreak-associated cases. Because measles is highly contagious, the agency stresses the importance of accurate case reporting to trigger timely public health interventions. The CDC’s choice to reclassify certain deaths and its criteria for labeling an infection as outbreak‑associated are subjects of ongoing discussion among epidemiologists and policymakers.
The rise in measles cases also comes at a time when the U.S. health landscape is being shaped by other public health challenges, including recent vaccine rollouts and outbreaks of other vaccine‑preventable diseases. While the CDC has focused its resources on monitoring and containing measles clusters, it has advised healthcare providers and parents to keep children up to date on the measles, mumps, and rubella (MMR) vaccine, especially as schools reopen.
State health departments are urged to intensify case investigations and contact tracing, particularly within communities reporting slower vaccination rates. The CDC’s data also suggest that the bulk of the 5,182 cases were spread through a relatively small number of outbreak clusters, meaning that strategic roll‑up of public health resources on hotspot areas could curb further spread.
Looking ahead, the CDC will likely continue to assess the efficacy of its follow‑up strategies, as well as clarify its death‑classification protocols to reconcile the differences observed in Pennsylvania’s reporting. Meanwhile, state officials and federal agencies remain on the front lines, racing to bring the certainty of vaccination frontiers back into the public sphere to prevent another surge in the coming years.
